HHS adolescent vaccination “hot buttons”
The HHS National Vaccines Advisory Committee's adolescent working group identifies three "hot button" issues concerning adolescent immunization: school mandates for vaccination, informed consent and use of non-traditional venues for adolescent immunization. The group hopes to publish a draft "defining the problems" in the upcoming months and put out a report within a year. A number of adolescent vaccines have been approved recently, including Merck's human papillomavirus vaccine Gardasil and Sanofi-Pasteur's meningococcal conjugate vaccine Menactra (1"The Pink Sheet" Feb. 28, 2005, p. 28)...
You may also be interested in...
Sanofi-Pasteur will have approximately 5 mil. doses of Menactra (meningococcal quadrivalent conjugate vaccine) available for use in the U.S. during the first 12 months following launch
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.